Treatment-associated decline in JAK2V617F allele burden in polycythemia vera: What does it mean?

IF 10.1 1区医学 Q1 HEMATOLOGY

American Journal of Hematology Pub Date : 2024-05-20 DOI:10.1002/ajh.27375

Ayalew Tefferi, Animesh Pardanani, Naseema Gangat

引用次数: 0

查看原文本刊更多论文

多发性红细胞症患者的 JAK2V617F 等位基因负担随治疗而下降：这意味着什么？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Hematology 医学-血液学

CiteScore

15.70

自引率

3.90%

发文量

363

审稿时长

3-6 weeks

期刊介绍： The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.

文献相关原料

公司名称	产品信息	采购帮参考价格